The World Health Organisation (WHO) said it's updating its guidelines on COVID-19 treatment to reflect the trial results of a common steroid in critical COVID-19 cases.
The preliminary results showed that dexamethasone reduced death rates by about one third for critically ill patients.
"This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support," WHO Director-General Tedros Adhanom Ghebreyesus said in a statement.
The agency said it will "coordinate a meta-analysis to increase our overall understanding of this intervention" and update the guidelines to "reflect how and when the drug should be used in COVID-19".
The drug has been used since the 1960s to reduce inflammation in diseases such as arthritis.
Israel's Netanyahu orders 'powerful attacks' in Gaza
At least 20 dead in operation against organized crime in Brazil's Rio
Hurricane Melissa to bring 'catastrophic situation' to Jamaica in storm of the century
Zelenskyy says Kyiv ready for peace talks, but will not cede territory
Vietnam's top tourist sites Hue, Hoi An suffer heavy flooding
No resolution as Afghanistan, Pakistan end peace talks in Istanbul
Japan PM Takaichi plans to recommend Trump for Nobel Peace Prize
Two killed in underground explosion at Australian silver mine
